Agile Therapeutics, Inc. (AGRX)
Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)
1.510
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2024

Agile Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Cash & Equivalents
2.565.2519.1414.4634.48
Upgrade
Short-Term Investments
---40.01-
Upgrade
Cash & Short-Term Investments
2.565.2519.1454.4734.48
Upgrade
Cash Growth
-51.26%-72.60%-64.86%57.98%339.17%
Upgrade
Receivables
3.393.381.530.87-
Upgrade
Inventory
2.741.330.97--
Upgrade
Prepaid Expenses
0.440.630.780.680.84
Upgrade
Other Current Assets
0.40.781.510.77-
Upgrade
Total Current Assets
9.5311.3623.9356.7935.32
Upgrade
Property, Plant & Equipment
0.490.8713.414.3814.2
Upgrade
Other Long-Term Assets
0.242.012.011.90.02
Upgrade
Total Assets
10.2614.2439.3373.0649.54
Upgrade
Accounts Payable
9.577.738.713.871.82
Upgrade
Accrued Expenses
9.133.913.563.351.8
Upgrade
Short-Term Debt
0.19----
Upgrade
Current Portion of Long-Term Debt
1.521.4316.83--
Upgrade
Current Portion of Leases
0.370.320.180.140.17
Upgrade
Total Current Liabilities
20.7813.3929.287.353.8
Upgrade
Long-Term Debt
---16.38-
Upgrade
Long-Term Leases
0.10.470.78--
Upgrade
Other Long-Term Liabilities
5.75.935.36--
Upgrade
Total Liabilities
26.5719.7935.4223.733.8
Upgrade
Common Stock
0--0.010.01
Upgrade
Additional Paid-In Capital
406.85403.16387.21361.54306.11
Upgrade
Retained Earnings
-423.17-408.7-383.29-312.22-260.37
Upgrade
Comprehensive Income & Other
---0-
Upgrade
Total Common Equity
-16.32-5.553.9249.3345.75
Upgrade
Shareholders' Equity
-16.32-5.553.9249.3345.75
Upgrade
Total Liabilities & Equity
10.2614.2439.3373.0649.54
Upgrade
Total Debt
2.172.2117.7916.520.17
Upgrade
Net Cash (Debt)
0.393.041.3537.9534.31
Upgrade
Net Cash Growth
-87.31%124.65%-96.44%10.62%336.98%
Upgrade
Net Cash Per Share
0.187.0227.84896.321388.05
Upgrade
Filing Date Shares Outstanding
6.860.930.070.040.03
Upgrade
Total Common Shares Outstanding
2.960.860.060.040.03
Upgrade
Working Capital
-11.25-2.03-5.3549.4331.52
Upgrade
Book Value Per Share
-5.51-6.4564.501126.671310.56
Upgrade
Tangible Book Value
-16.32-5.553.9249.3345.75
Upgrade
Tangible Book Value Per Share
-5.51-6.4564.501126.671310.56
Upgrade
Machinery
0.250.2514.614.3314.43
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q